| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 903,221 | 912,687 | 863,984 | 896,522 | | Cost of Revenue | 684,071 | 686,462 | 675,942 | 759,891 | | | Gross Profit | 219,150 | 226,225 | 188,042 | 136,631 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 100,154 | 111,219 | 111,405 | 63,589 | | Non Recurring | 15,154 | 13,812 | 11,041 | 482,866 | | Others | 47,020 | 44,687 | 51,662 | 23,928 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 56,822 | 56,507 | 13,934 | (433,752) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,056 | (2,001) | (7,518) | (21,477) | | Earnings Before Interest And Taxes | 58,878 | 54,506 | 6,416 | (455,229) | | Interest Expense | 36,457 | 31,065 | 22,149 | 25,989 | | Income Before Tax | 22,421 | 23,441 | (15,733) | (481,218) | | Income Tax Expense | 8,155 | 8,549 | (4,809) | (87,002) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,266 | 14,892 | (10,924) | (394,216) | | | Non-recurring Events | | Discontinued Operations | 422 |
-
|
-
| 998 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,688 | 14,892 | (10,924) | (393,218) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,688 | $14,892 | ($10,924) | ($393,218) |
|
0.51% Nasdaq 
Income Statement
